In vitro percutaneous absorption of prednisolone derivatives based on solubility parameter

International Journal of Pharmaceutics

Volumn 158, Issue 1, 1997, Pages 11-18

  Hashiguchi, Terushi ^a   Yasutake, Takuji ^a   Manako, Takafumi ^a   Otagiri, Masaki ^b  

^a HISAMITSU PHARMACEUTICAL CO INC   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Accumulation; Distribution; In vitro percutaneous absorption; Lipophilicity; Prednisolone derivatives; Solubility parameter

Indexed keywords

PREDNISOLONE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; DRUG DIFFUSION; DRUG DISTRIBUTION; DRUG SOLUBILITY; LIPOPHILICITY; MOUSE; NONHUMAN; PARTITION COEFFICIENT; PRIORITY JOURNAL; SKIN ABSORPTION; SKIN PERMEABILITY;

EID: 0030781712     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(97)00205-6     Document Type: Article

References (17)

1. Barton, A.M.F., 1975. Solubility parameters. Chem. Rev. 75, 731-753.
2. Brattsand, R., Sarnstrand, B., 1989. Prospects for future topical glucocorticoids development. Acta Derm.-Venereol. 69. 37-46.
3. Chertkoff, M.J., Martin, A.N., 1960. The solubility of benzoic acid in mixed solvents. J. Pharm. Sci. 49, 444-447.
4. Davis, S.S., 1970. Molar attraction constants applied to structure activity relationships. Experimentia 26, 671-672.
5. Fedors, R.F.A., 1974. Method for estimating both the solubility parameters and molar volumes of liquids. Polym. Eng. Sci. 14, 147-154.
6. Flynn, G.L., Yalkowsky, S.H., 1972. Membrane diffusion III: Influence of solvent composition and permeant solubility on membrane transport. J. Pharm. Sci. 61, 838-852.
7. Komatzu, H., Okamoto, H., Miyagawa, K., Hashida, M., Sezalci, H., 1986. Percutaneous absorption of butylparaben from liposomes in vitro. Chem. Pharm. Bull. 34, 3423-3430.
8. Lin, H.H., Hsu, L.R., Wu, P.C., Tsai, Y.H., 1995. Increased norfloxacin skin permeability for fatty alcohol propylene glycol (FAPG) ointment by optimized process of preparation: Behavior of stearic acid in stratum corneum lipids. Biol. Pharm. Bull. 18, 1560-1565.
9. Liron, Z., Choen, S., 1984. Percutaneous absorption of alkanoic acids. II. Application of regular solution theory. J. Pharm. Sci. 73, 538-542.
10. Loftsson, T., Bodor, N., 1981. Improved delivery through biological membrane X. Percutaneous absorption and metabolism of methylsulfinylmethyl 2-acetoxy benzoate and related aspirin prodrugs. J. Pharm. Sci. 70, 756-758.
11. Miyake, H., Terada, H., 1982. Determination of partition coefficients of very hydrophobic compounds by high-performance liquid chromatography on glyceryl-coated controlled-pore glass. J. Chromatogr. 240, 9-20.
12. Rougier, A., Lotte, C., Maibach, H.I., 1987. The hairless rat: A relevant animal model to predict in vivo percutaneous absorption in humans. J. Invest. Dermatol. 88, 577-581.
13. Schuplein, R.J., Blank, I.H., Brauner, G.L., Macfarlane, D.J., 1969. Percutaneous absorption of steroids. J. Invest. Dermatol. 52, 63-70.
14. Tomita, Y., Ozawa, M., Katsuura, H., 1984. New methods for determination of n-octanol-water partition coefficient. J. Hygenic Chem. 6, 3-11.
15. Tayer, N.E., Tsai, R., Testa, B., Carrupt, P., Hansch, C., Leo, A., 1991. Percutaneous penetration of drugs: A quantitative structure-permeability relationship study. J. Pharm. Sci. 80, 744-749.
16. Waranis, R.P., Silver, K.G., Sloan, K.B., 1987. The solubility parameter of vehicles as a predictor of relative vehicle effects on the diffusion of 6-mercaptopurine. Int. J. Pharm. 36, 211-222.
17. Yamaoka, K., Tanigawara, Y., Nakagawa, T., Uno, T.A, 1981. Pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharmacobio-Dyn. 4, 879-885.